Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in CashDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avai Bio (AVAI) Cash from Financing Activities (2018 - 2024)

Avai Bio's Cash from Financing Activities history spans 6 years, with the latest figure at $135907.0 for Q1 2024.

  • For Q1 2024, Cash from Financing Activities fell 16.19% year-over-year to $135907.0; the TTM value through Mar 2024 reached $1.4 million, up 741.27%, while the annual FY2025 figure was $1.2 million, 9.0% down from the prior year.
  • Cash from Financing Activities for Q1 2024 was $135907.0 at Avai Bio, down from $705085.0 in the prior quarter.
  • Across five years, Cash from Financing Activities topped out at $705085.0 in Q4 2023 and bottomed at -$55248.0 in Q3 2022.
  • The 4-year median for Cash from Financing Activities is $87341.0 (2022), against an average of $152917.6.
  • The largest annual shift saw Cash from Financing Activities tumbled 320.86% in 2020 before it soared 4091.42% in 2023.
  • A 4-year view of Cash from Financing Activities shows it stood at -$13296.0 in 2020, then crashed by 32.86% to -$17665.0 in 2022, then skyrocketed by 4091.42% to $705085.0 in 2023, then tumbled by 80.72% to $135907.0 in 2024.
  • Per Business Quant, the three most recent readings for AVAI's Cash from Financing Activities are $135907.0 (Q1 2024), $705085.0 (Q4 2023), and $421363.0 (Q3 2023).